Fumarate induces vesicular release of mtDNA to drive innate immunity
University of Cambridge · Medical Research Council · +15 more institutions
Abstract
Abstract Mutations in fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma 1 . Loss of FH in the kidney elicits several oncogenic signalling cascades through the accumulation of the oncometabolite fumarate 2 . However, although the long-term consequences of FH loss have been described, the acute response has not so far been investigated. Here we generated an inducible mouse model to study the chronology of FH loss in the kidney. We show that loss of FH leads to early alterations of mitochondrial morphology and the release of mitochondrial DNA (mtDNA) into the cytosol, where it triggers the activation of the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes…
Citation impact
- FWCI
- 46.95
- Percentile
- 100%
- References
- 45
Authors
27- VZVincent ZecchiniCorresponding
University of Cambridge, Medical Research Council
- VPVincent Paupe
University of Cambridge, MRC Mitochondrial Biology Unit, Medical Research Council
- IHIrene Herranz-Montoya
University of Cambridge, Spanish National Cancer Research Centre, Molecular Oncology (United States), Medical Research Council
- JJJoëlle J. E. Janssen
University of Cambridge, Medical Research Council, Wageningen University & Research
- IMInge M. N. Wortel
Radboud University Nijmegen, University of Cambridge, Medical Research Council
Topics & keywords
- Fumarase
- Cell biology
- Biology
- Innate immune system
- Mitochondrion
- Mitochondrial DNA
- Dimethyl fumarate
- mitochondrial fusion
Funding
- NSNational Science Foundation
- CRCancer Research UKAward: C51061/A27453
- ECEuropean CommissionAward: 749926
- SNSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungAward: CRSII5_180326
- DSDaiichi Sankyo Foundation of Life Science
- UZUniversität zu Köln
- MRMedical Research CouncilAwards: MC_UU_00028/5, MC_UU_00015/7, MC_UU_12022/6, MC_UU_00028/5, MRC_MC_UU_12022/6, MC_ UU_00015/7
- CRCancer Research UK Cambridge Institute, University of Cambridge
- DSDaiichi Sankyo Europe